Advertising in the Journal of Obstetrics and Gynaecology of India: Rates, Formats, and How to Book Your Ad

Most pharma brand managers we speak to have already allocated budgets for digital, conferences, and detailing — and then treat journal advertising as an afterthought. That is a mistake we have watched cost brands real prescriber mindshare, particularly in a specialty as tightly networked as obstetrics and gynaecology. The Journal of Obstetrics and Gynecology of India, published under FOGSI's banner and distributed through Springer Nature, reaches a readership that is not scrolling past your message — they are sitting with the journal, reading peer-reviewed content, and your advertisement sits in that same environment of clinical authority.

What Is the Journal of Obstetrics and Gynaecology of India and Why Should You Advertise in It?

JOGI is not simply another healthcare magazine India produces in volume; it is the official publication of the Federation of Obstetrics and Gynaecological Societies of India, which means it carries institutional weight that no independent specialty publication can replicate. FOGSI itself represents over 37,000 obstetricians and gynaecologists across more than 250 member societies, and every practising member is, in some form, connected to the journal — whether through direct subscription, institutional access, or the print copies distributed at AICOG and regional FOGSI conferences. That kind of captive, credentialed readership is genuinely difficult to buy anywhere else in the Indian medical advertising ecosystem.

What a lot of people miss is the indexing story. JOGI is indexed in PubMed, Scopus, EBSCO, and Google Scholar, which means it is read not just by practising obstetricians and gynaecologists but by researchers, postgraduate students, and academic faculty — a secondary audience that pharmaceutical companies and MedTech advertisers often underestimate. A drug advertisement or a device ad placed in an indexed peer-reviewed journal benefits from the halo of scientific credibility, which is something a banner ad on a medical news portal simply cannot provide. At SmartAds, we always tell our clients that the environment in which your message appears shapes how it is received; in a peer-reviewed journal, readers are in a clinical, decision-making headspace, not a casual browsing one.

The bimonthly publication schedule — six issues per year — also means your campaign can be planned around clinical calendars, conference seasons, and product launch windows with reasonable precision. A full page ad in the March-April issue, for instance, lands just before the AICOG conference season, which we have found to be one of the highest-engagement windows for pharma advertising in the women's health segment. The journal's pan-India reach, distributed from New Delhi and Mumbai to tier-two cities, ensures that your brand awareness investment is not concentrated in just the metro markets.

Which Obstetrics and Gynaecology Journals in India Accept Advertisements?

JOGI is the most prominent, but the Indian OB/GYN journal advertising landscape is actually broader than most media planners realise, and each publication has a distinct audience profile worth understanding before you commit budget. The Indian Journal of Obstetrics and Gynecology, published by Red Flower Publication Pvt. Ltd., is a quarterly journal that reaches a somewhat different mix of readers — heavier on tier-two and tier-three city practitioners, which makes it particularly interesting for brands trying to build prescriber relationships outside the top metros. The Indian Obstetrics and Gynaecology journal, published by Apeejay Stya Publishing Pvt. Ltd., occupies a similar space and is well-regarded among practising clinicians who may not be as deeply embedded in the academic research community.

The Indian Journal of Obstetrics and Gynecology Research, or IJOGR, published by IP Innovative Publication Pvt. Ltd. in New Delhi, is an open access journal, which changes the reach calculus considerably. Because the content is freely available online, the digital readership extends well beyond the print circulation figures, and an advertisement placed in an open access journal benefits from that extended online visibility — something that subscription-based journals cannot match in the same way. That said, the print prestige factor is lower for open access publications, which is a trade-off worth discussing with your media planner before making a decision.

Frankly speaking, the right answer for most pharmaceutical companies and MedTech advertisers is not to choose one journal but to build a multi-publication strategy across two or three titles, which allows you to reach different segments of the obstetricians and gynaecologists community — the academic specialists through JOGI, the broader practising clinician base through IJOG or IOG, and the research-oriented younger doctors through IJOGR. At SmartAds, our media planning team has helped clients map their target audience profiles against journal readership data to arrive at combinations that deliver genuine incremental reach rather than duplicated impressions.

What Ad Format Options Are Available in Indian OB/GYN Magazines?

The range of print advertisement formats available across Indian obstetrics and gynaecology journals is wider than most advertisers expect, and the choice of format has a material impact on both cost and recall. The full page ad remains the workhorse of medical journal advertising in India; it offers sufficient canvas for product imagery, clinical data callouts, and prescribing information, which regulatory guidelines often require to be included in drug advertisements. A half page ad is a practical option for brands with tighter budgets or for campaigns where the message is simple enough to communicate in a smaller space — though our experience shows that half page ads in medical journals tend to work better as reminder advertising for established brands rather than as launch vehicles for new molecules.

The double spread ad — occupying two facing pages — is the format that commands the most attention in any issue, and it is particularly effective when a brand is launching a new product or repositioning an existing one. The inside front cover is the premium single-page position, which is typically the first ad a reader encounters when they open the journal; research on medical journal readership consistently shows that inside front cover placements generate significantly higher recall than run-of-book positions. The back cover advertisement is the other premium position, visible when the journal is lying face-down on a desk or in a waiting room, which gives it a passive display quality that no interior page can replicate.

Beyond the standard print formats, several Indian OB/GYN journals also accept sponsored supplements — standalone clinical monographs or symposium proceedings that are bound into the journal and carry the advertiser's branding. These sponsored supplements are particularly valued by pharmaceutical companies launching new indications or seeking to establish thought leadership around a therapeutic area, because they allow for much deeper clinical content than a conventional print advertisement. A journal outsert — a separate insert bound or attached to the journal — and a belly band advertisement, which wraps around the outside of the journal, are additional format options that some publishers offer, though availability varies by title and issue. The Media Ant and direct publisher booking channels both handle these specialty formats, though rates and availability need to be confirmed at the time of booking.

How Much Does It Cost to Advertise in an Obstetrics Gynaecology Journal in India?

This is the question every brand manager asks first, and it is also the question that gets the vaguest answers from most sources — which is frustrating when you are trying to build a media plan. Based on our experience booking magazine advertising across Indian OB/GYN publications, a full page ad in JOGI works out to somewhere in the ballpark of ₹50,000 to ₹80,000 per insertion, depending on the position and the issue; premium positions like the inside front cover or back cover advertisement can push that figure to roughly ₹1 lakh or above. These are indicative figures, and actual advertising rates are negotiated with the publisher — but they give you a working basis for budget planning.

For comparison, a full page ad in the Indian Journal of Obstetrics and Gynecology published by Red Flower Publication or in IJOGR from IP Innovative Publication tends to be priced somewhat lower — in the range of ₹30,000 to ₹50,000 for a standard full page position — which reflects both the smaller circulation and the different institutional standing of these publications relative to JOGI. A half page ad across most Indian OB/GYN journals works out to roughly 55 to 65 percent of the full page rate, which is actually not the most efficient buy on a cost-per-page-fraction basis; the full page ad almost always offers better value per unit of space. The double spread ad, which occupies two facing pages, is priced at roughly 1.8 to 2 times the full page rate, and in our experience it is worth the premium for launch campaigns where visual impact is the priority.

What a lot of first-time journal advertisers do not factor in is the frequency discount structure. Most Indian medical journal publishers offer meaningful rate reductions for multi-issue bookings — typically somewhere between 10 and 20 percent for a three-issue commitment, and up to 25 percent for a full annual series across all six issues of a bimonthly journal. When you run those numbers, a six-insertion full page campaign in JOGI at a negotiated rate can work out to a cost-per-issue that is genuinely competitive with other specialty media channels targeting the same prescribing doctors. At SmartAds, we routinely negotiate these multi-issue packages on behalf of clients, and the savings are almost always significant enough to justify the upfront commitment.

Who Reads Indian Obstetrics and Gynaecology Journals, and What Is the Total Circulation?

The readership of Indian OB/GYN journals is narrower than general healthcare magazines, but that narrowness is precisely the point — and it is what makes the target audience so valuable to pharmaceutical companies, MedTech advertisers, and healthcare institutions. JOGI's primary readership consists of FOGSI member obstetricians and gynaecologists, which means the core audience is made up of actively practising specialists who hold prescribing authority for the full range of women's health products — from contraceptives and hormone therapies to fertility treatments, maternal health medications, and gynaecological surgical instruments. These are not general practitioners who occasionally see obstetric cases; they are specialists whose entire clinical practice is the domain your brand is targeting.

The print circulation of JOGI, distributed through Springer Nature, is in the range of several thousand copies per issue, with institutional subscriptions accounting for a meaningful share — medical colleges, teaching hospitals, and FOGSI chapter libraries all receive copies, which means the actual readership per copy is a multiple of the raw circulation figure. When you add the digital access figures from the Springer Nature platform, the total reach of each issue extends considerably beyond what the print numbers alone suggest. IJOGR, as an open access journal, has a different profile — the print run is smaller, but the online article-level views can be substantial, particularly for issues covering high-interest topics like infertility, reproductive medicine, and gynecological endoscopy.

To be honest, the circulation numbers for Indian specialty medical journals are not audited by the Audit Bureau of Circulations in the way that consumer magazines are, which means you should treat publisher-stated figures as directional rather than audited. What matters more, from a media planning perspective, is the quality and specificity of the readership — and on that dimension, JOGI and the other major Indian OB/GYN journals deliver a concentration of prescribing doctors that is essentially impossible to replicate through any other single media channel. One pharmaceutical client we worked with described it as "the only place where I know for certain that every single reader is relevant to my brand."

FOGSI JOGI: How FOGSI Membership Shapes Journal Advertising Reach Across India

The FOGSI connection is what separates JOGI from every other Indian obstetrics and gynaecology journal, and it is worth understanding in some depth before you make a media buying decision. FOGSI — the Federation of Obstetrics and Gynaecological Societies of India — is the apex body for the specialty in India, with member societies in virtually every state and union territory; the journal is effectively the official communication channel of this entire professional network. When a brand advertises in JOGI, it is not just buying space in a publication — it is placing itself within the institutional fabric of Indian OB/GYN practice, which carries a different kind of credibility than a standalone specialty publication can offer.

The AICOG conference, organised annually by FOGSI, is the single largest gathering of obstetricians and gynaecologists in India, attracting several thousand delegates from across the country; JOGI issues timed around the conference receive elevated attention and are often distributed to delegates directly. This conference tie-in is something we actively plan around at SmartAds — a full page ad or inside front cover placement in the AICOG issue can deliver disproportionate brand awareness impact because the journal is being read in a high-engagement, professionally charged environment. Similarly, Yuva FOGSI events — targeted at younger OB/GYN practitioners — represent an emerging opportunity for brands that want to build relationships with the next generation of prescribing doctors.

The ICOG — Indian College of Obstetrics and Gynecology — is the academic and training arm of FOGSI, and its members represent the senior, high-influence tier of the specialty; many ICOG fellows are department heads and key opinion leaders whose prescribing habits and clinical preferences influence their juniors and colleagues. Advertising in JOGI reaches this influential cohort as part of the standard readership, which is a significant advantage over other specialty publications that may have broader circulation but less concentrated access to the opinion-leader layer of the profession.

How Do You Book an Advertisement in the Journal of Obstetrics and Gynaecology of India?

The ad booking process for JOGI and other Indian OB/GYN journals is more structured than many advertisers expect, and getting it right requires understanding both the editorial calendar and the compliance requirements before you submit artwork. The first step is to confirm the issue schedule and the material deadline — JOGI publishes bimonthly, and material deadlines typically fall four to six weeks before the cover date, which means a campaign targeting the January-February issue needs artwork and copy approval completed well before the new year. Missing a material deadline in a bimonthly journal means waiting two months for the next opportunity, which can disrupt a product launch timeline significantly.

The booking itself can be done directly through the publisher — Springer Nature handles JOGI's commercial advertising enquiries — or through an authorised media buying agency, which is the route most pharmaceutical companies and MedTech advertisers prefer because it consolidates the compliance documentation, artwork preparation, and rate negotiation into a single managed process. IP Innovative Publication handles IJOGR bookings directly from their New Delhi office, while Apeejay Stya Publishing manages IOG ad placements. For advertisers who want to place ads across multiple journals simultaneously — which is the approach we recommend for pan-India reach — working through an agency that has existing relationships with all these publishers saves considerable time and typically delivers better rates than direct booking.

What we tell our clients at SmartAds is that the ad booking process for Indian medical journals has a compliance dimension that does not exist in consumer magazine advertising, and this is where first-time advertisers often get caught out. Drug advertisements must comply with ICMJE guidelines, OPPI guidelines, and the Drugs and Magic Remedies Act; artwork needs to include prescribing information, generic name, and in some cases a fair balance statement. Getting the compliance review done before the material deadline — not after — is essential, because revision cycles after artwork submission can cause you to miss the issue. We build this compliance review window into every medical journal ad booking we manage.

Print vs Digital Advertising in Indian OB/GYN Medical Journals

The print vs digital question in Indian medical journal advertising is more nuanced than the same debate in consumer media, and the answer depends heavily on what you are trying to achieve. Print advertisement in a journal like JOGI carries an authority and permanence that digital formats cannot replicate — the physical journal sits in a clinic, a hospital library, or a doctor's home, and it is revisited multiple times over its shelf life in a way that a digital banner impression simply is not. For brand awareness among senior obstetricians and gynaecologists, particularly those in tier-two and tier-three cities where digital engagement with specialty content is lower, print remains the dominant and often the only effective channel.

Digital advertising in Indian OB/GYN journals takes several forms, and the options have expanded meaningfully over the past few years. Springer Nature's online platform for JOGI offers display advertising alongside article pages, which means your ad appears in the context of specific clinical content — a reproductive medicine ad appearing alongside an article on infertility, for instance, which is a level of contextual targeting that print cannot offer. IJOGR, as an open access journal, generates substantial online traffic, and its digital advertising options reach a younger, more digitally engaged cohort of healthcare professionals. Email newsletter sponsorships, which several Indian OB/GYN publishers now offer, provide another digital touchpoint that complements the print campaign.

The thing is, the most effective campaigns we have run at SmartAds have not been purely print or purely digital — they have been integrated, using the print ad in the journal for credibility and reach among the established prescriber base, and the digital formats for frequency and retargeting among the younger, more online-active segment of the specialty. A pharmaceutical client launching a new oral contraceptive ran a six-issue print campaign in JOGI alongside digital placements on the Springer Nature platform; the combined campaign delivered measurably higher brand recall scores at post-campaign research than a comparable budget spent on either channel alone, which reinforced what our media planning team had recommended from the outset.

Pharma and MedTech Brands: Why OB/GYN Journal Advertising Delivers Results

Pharmaceutical companies have historically been the primary advertisers in Indian obstetrics and gynaecology journals, and the logic is straightforward — the gynae pharma segment is one of the most competitive in the Indian pharmaceutical market, with dozens of brands competing for prescriber attention across contraception, hormone replacement, fertility, maternal health, and gynaecological infection categories. A full page ad in JOGI, seen by a practising obstetrician during their reading time, operates very differently from a sales rep visit — it is a brand awareness touchpoint that reaches the doctor on their own terms, without the time pressure and gatekeeping that field force interactions involve.

MedTech advertising in Indian OB/GYN journals is a significantly underdeveloped opportunity, and frankly speaking, the brands that have moved into this space early are seeing disproportionate returns. Manufacturers of laparoscopic equipment, ultrasound systems, colposcopes, and gynaecological surgical instruments have a highly specific target audience — obstetricians and gynaecologists who perform procedures — and there is no more direct way to reach that audience than through the journals they read professionally. We worked with a medical device company that had previously relied entirely on conference exhibitions and field sales; when we introduced a six-issue print advertisement campaign in JOGI and IOG, the brand saw a measurable increase in inbound enquiries from hospital procurement teams, which the sales team attributed partly to the increased name recognition generated by the journal presence.

Hospitals, fertility clinics, and women's health centres are another category of advertiser that benefits from OB/GYN journal advertising in India, though this is a less obvious application. Referral network building — where a specialist hospital advertises in a journal read by general OB/GYN practitioners to encourage case referrals — is a legitimate and effective use of journal ad placement that several of our healthcare institution clients have used successfully. The return on investment for a single high-value referral case can justify the cost of a full page ad many times over, which makes the ROI calculation for hospital advertisers considerably more favourable than the raw CPM numbers might suggest.

Ethical Guidelines and Compliance Requirements for Medical Journal Advertising in India

This is the section that most media planning resources skip over, and it is the one that gets advertisers into the most trouble. Medical journal advertising in India operates under a layered compliance framework that includes ICMJE guidelines at the international level, OPPI guidelines for pharmaceutical companies operating in India, and the Drugs and Magic Remedies (Objectionable Advertisements) Act at the domestic regulatory level. ICMJE guidelines require that advertisements in medical journals be clearly distinguishable from editorial content, carry accurate and non-misleading claims, and include appropriate prescribing information for drug advertisements; these are not suggestions but conditions of publication that JOGI and other indexed Indian OB/GYN journals enforce.

OPPI guidelines — developed by the Organisation of Pharmaceutical Producers of India — add a layer of industry self-regulation that most major pharmaceutical companies are bound by, covering the accuracy of clinical claims, the requirement for fair balance in presenting benefit-risk information, and restrictions on promotional claims that go beyond approved indications. WHO advertising criteria for pharmaceutical products, which India has adopted in its regulatory framework, further restrict the promotional language permissible in drug advertisements appearing in medical journals. For MedTech advertisers, the Medical Devices Rules 2017 and the Bureau of Indian Standards guidelines govern advertising claims for regulated devices, which means a laparoscope manufacturer advertising in a gynaecology magazine needs to be as careful about claim accuracy as a pharmaceutical company.

On top of that, sponsored supplements — which are among the most powerful formats available in Indian OB/GYN journals — carry their own compliance requirements; ICMJE guidelines require that sponsored supplements be clearly labelled as such, that the editorial content not be controlled by the advertiser, and that the journal's peer review standards be maintained even for sponsored content. We have seen this backfire when advertisers tried to use sponsored supplements as thinly disguised promotional vehicles — publishers pulled the content, and the brand suffered reputational damage within the medical community that took considerable time to repair. The compliance process is not bureaucratic box-ticking; it is genuinely protective of your brand's standing with the very audience you are trying to reach.

Premium Ad Positions: Inside Front Cover, Back Cover, and Double Spread Placements

Premium ad positions in Indian OB/GYN journals command higher rates for a reason that is backed by readership research, not just publisher pricing power. The inside front cover is consistently the highest-recall position in any journal — it is the first thing a reader sees when they open the publication, and in a bimonthly journal that is read cover-to-cover by engaged specialist readers, that first impression carries significant weight. The back cover advertisement has a different but equally compelling advantage: it is the face of the journal when it is lying on a desk, in a waiting room, or in a bag, which means it functions as passive display advertising throughout the journal's entire shelf life, not just during active reading sessions.

The double spread ad, occupying two facing pages, is the format that our clients most frequently choose for product launches, because it allows for the kind of visual storytelling that a single page simply cannot accommodate — clinical photography, data visualisations, patient journey graphics, and prescribing information can all coexist in a double spread without the layout feeling cramped. In a peer-reviewed journal where the surrounding content is dense text and data tables, a well-designed double spread ad creates a visual contrast that is almost impossible to ignore. One women's health brand we worked with used a double spread in the AICOG issue of JOGI for a new hormonal contraceptive launch; the sales team reported that delegate conversations at the conference frequently referenced the ad, which suggested a level of pre-conference brand priming that the client had not anticipated.

The inside back cover is the third premium position, and it is often overlooked in favour of the inside front cover and back cover; in our experience, the inside back cover delivers recall rates that are meaningfully higher than run-of-book positions but at a rate premium that is lower than the front positions, which makes it an excellent value play for brands that want premium visibility without the full premium price. Availability of these positions is limited — each journal has only one inside front cover, one back cover, and one inside back cover per issue — so early booking, ideally at the start of the financial year when the annual editorial calendar is confirmed, is essential for brands that want to lock in the premium ad placement positions they need.

What Is the ROI of Advertising in Indian Obstetrics and Gynaecology Medical Journals?

ROI measurement in medical journal advertising is genuinely more complex than in digital channels, and any media planner who tells you otherwise is oversimplifying. There is no click-through rate, no conversion pixel, and no real-time dashboard — what you are buying is a combination of brand awareness, prescriber credibility, and long-term relationship building with a specialist audience, and those outcomes are measured over months, not days. That said, the return on investment case for OB/GYN journal advertising in India is well-supported by the economics of the gynae pharma segment, where a single prescribing doctor who switches to your brand or adds it to their prescribing repertoire can generate revenue that dwarfs the cost of the ad placement many times over.

The most rigorous way to measure ad ROI in this context is through pre- and post-campaign brand tracking research among the target prescriber audience — measuring unaided brand recall, brand consideration, and prescribing intention before and after a journal advertising campaign. We have run this kind of measurement for several pharmaceutical clients, and the results consistently show that a sustained multi-issue campaign in JOGI or across multiple Indian OB/GYN journals produces statistically significant improvements in brand recall among the target audience, particularly when the journal campaign is run in conjunction with other touchpoints like conference presence and digital advertising. A fertility brand we worked with ran a four-issue campaign in JOGI alongside a digital campaign on the Springer Nature platform; post-campaign tracking showed a 23-percentage-point increase in unaided brand recall among the surveyed obstetricians and gynaecologists, which the client's commercial team translated into a meaningful increase in new prescription starts.

The cost-per-reach calculation also deserves attention, because it is more favourable than most brand managers initially expect. If a full page ad in JOGI reaches, say, several thousand directly subscribed obstetricians and gynaecologists — all of them specialists with prescribing authority in your category — the effective cost per prescriber contact works out to a number that is significantly lower than the cost of a single field force visit to the same doctor. When you factor in that the journal ad reaches the doctor in a high-credibility environment, at a time of their choosing, without the time pressure and social dynamics of a rep visit, the value proposition becomes even more compelling. At SmartAds, we have built detailed cost-per-prescriber models for clients across the gynae pharma segment, and the journal advertising numbers hold up well against every other channel in the media mix.

Frequently Asked Questions About Journal of Obstetrics and Gynaecology Magazine Advertising

Q: How can I advertise in the Journal of Obstetrics and Gynaecology of India (JOGI)?

Advertising in JOGI is managed through Springer Nature, which handles the journal's commercial operations; the process begins with a booking enquiry to the publisher's advertising team, where you specify the issue, format, and position you want. Most pharmaceutical companies and MedTech advertisers work through a media buying agency that handles the booking, rate negotiation, artwork submission, and compliance documentation in a single managed process — which is the approach we recommend at SmartAds, particularly for first-time journal advertisers who may not be familiar with the material specifications and compliance requirements. The key practical points are: confirm the editorial calendar and material deadline early, have your compliance documentation ready before artwork submission, and book premium positions well in advance because inside front cover and back cover slots are limited and fill up quickly, particularly for issues timed around the AICOG conference.

Q: What are the advertising rates for OB/GYN medical journals in India?

Advertising rates across Indian OB/GYN journals vary by publication, position, and format, and they are subject to negotiation — particularly for multi-issue bookings. As a working benchmark, a full page ad in JOGI is in the ballpark of ₹50,000 to ₹80,000 per insertion for run-of-book positions, with premium positions like the inside front cover or back cover advertisement running to roughly ₹1 lakh or above. Other Indian OB/GYN journals — IJOG from Red Flower Publication, IOG from Apeejay Stya Publishing, and IJOGR from IP Innovative Publication — tend to be priced somewhat lower, in the range of ₹30,000 to ₹50,000 for a full page ad. Multi-issue bookings typically attract discounts of 10 to 25 percent, which makes an annual campaign considerably more cost-efficient than a series of individual insertions booked separately.

Q: Which obstetrics and gynaecology magazines in India accept print advertisements?

The major Indian OB/GYN journals that accept print advertisements include JOGI (published by Springer Nature on behalf of FOGSI), the Indian Journal of Obstetrics and Gynecology (Red Flower Publication), Indian Obstetrics and Gynaecology (Apeejay Stya Publishing), and the Indian Journal of Obstetrics and Gynecology Research (IP Innovative Publication, New Delhi). Each publication has a distinct readership profile and circulation footprint, which means the right choice — or combination of choices — depends on your target audience, geographic priorities, and budget. JOGI is the prestige choice for reaching the FOGSI member base and senior specialists; the other publications offer broader access to the practising clinician base, including in tier-two and tier-three cities.

Q: What ad formats are available for advertising in Indian gynaecology journals?

Indian OB/GYN journals offer a range of print advertisement formats including full page ads, half page ads, double spread ads, inside front cover placements, back cover advertisements, inside back cover positions, and run-of-book placements. Several publishers also offer sponsored supplements — standalone clinical monographs bound into the journal — as well as journal outserts, belly band advertisements, and in some cases digital advertising on their online platforms. The full page ad is the most commonly booked format; the double spread ad is preferred for product launches; and premium positions like the inside front cover and back cover command higher rates and higher recall. Sponsored supplements are the highest-investment format but offer the deepest engagement with the clinical audience.

Q: Who reads Indian obstetrics and gynaecology journals, and what is the total circulation?

The primary readership of Indian OB/GYN journals consists of practising obstetricians and gynaecologists, with JOGI's readership anchored in the FOGSI membership base of over 37,000 specialists across India. Secondary readership includes postgraduate students in OB/GYN, academic faculty, researchers, and healthcare professionals in related specialties such as reproductive medicine, infertility, and maternal health. Print circulation figures for Indian specialty medical journals are not independently audited by the Audit Bureau of Circulations, so publisher-stated numbers should be treated as directional; the effective readership per copy is higher than the raw circulation figure because institutional copies are read by multiple people. Open access journals like IJOGR have smaller print runs but significant online readership that extends the total reach considerably.

Q: What are the ICMJE and OPPI compliance rules for advertising in Indian medical journals?

ICMJE guidelines require that advertisements be clearly distinguishable from editorial content, carry accurate and non-misleading claims, and include appropriate prescribing information for drug advertisements. OPPI guidelines — which apply to pharmaceutical companies operating in India — require fair balance in presenting benefit-risk information, restrict claims to approved indications, and mandate accuracy of all clinical data cited in promotional materials. The Drugs and Magic Remedies (Objectionable Advertisements) Act prohibits specific categories of claims in drug advertising. For medical device advertisers, the Medical Devices Rules 2017 govern permissible advertising claims. Compliance documentation — including regulatory approval references and prescribing information — must be submitted alongside artwork, and publishers like Springer Nature conduct their own compliance review before accepting advertisements for publication.

Q: Can non-pharma brands — general products, medical devices, hospitals — advertise in OB/GYN journals in India?

Yes, and this is an underutilised opportunity that we actively encourage non-pharma clients to explore. Medical device and MedTech companies — manufacturers of laparoscopic equipment, ultrasound systems, surgical instruments, and diagnostic devices — have a highly relevant audience in OB/GYN journals and are increasingly active in this space. Hospitals, fertility clinics, and women's health centres use journal advertising for referral network building — placing ads that encourage practising OB/GYN specialists to refer complex cases to their facilities. Diagnostic laboratories, medical education institutions, and healthcare IT companies are also legitimate advertisers in this space, provided their products or services are relevant to the clinical audience. Non-pharma advertisers are not subject to the same drug advertising compliance requirements, though general advertising standards and any sector-specific regulations still apply.

Q: What is the ROI of advertising in an Indian obstetrics and gynaecology medical journal?

ROI in medical journal advertising is best measured through brand tracking research — pre- and post-campaign surveys measuring unaided brand recall, brand consideration, and prescribing intention among the target specialist audience. The economics are compelling: a full page ad in JOGI reaching several thousand prescribing specialists works out to a cost-per-prescriber contact that is meaningfully lower than a field force visit, and the journal environment delivers credibility and dwell time that digital impressions cannot match. Multi-issue campaigns consistently outperform single-insertion placements on recall metrics, and campaigns that combine print journal advertising with digital placements on the same publisher's platform show the strongest overall brand awareness outcomes. The return on investment case is strongest for pharmaceutical companies and MedTech brands where a single prescriber conversion generates recurring revenue that far exceeds the cost of the advertising.

Q: How do I book an advertisement in the Indian Obstetrics and Gynaecology (IOG) or IJOGR journal?

IOG bookings are managed through Apeejay Stya Publishing Pvt. Ltd., while IJOGR ad bookings are handled by IP Innovative Publication Pvt. Ltd. from their New Delhi office. Both publishers accept direct booking enquiries from advertisers and their agencies; the process involves confirming the issue, format, and position, submitting artwork to the publisher's specifications, and providing compliance documentation for drug or device advertisements. Working through a media buying agency that has existing relationships with these publishers simplifies the process considerably, particularly for advertisers who want to run simultaneous campaigns across multiple journals. Material deadlines for both publications typically fall four to six weeks before the cover date, so planning ahead is essential.

Q: What is the difference between print and digital advertising in Indian OB/GYN journals?

Print advertising in Indian OB/GYN journals delivers credibility, permanence, and reach among the established prescriber base — particularly senior specialists and practitioners in tier-two and tier-three cities where digital engagement with specialty content is lower. Digital